

Long before the emergence of COVID-19, cardiovascular diseases (CVD) had already established themselves as the leading cause of morbidity and mortality worldwide.1 Notably, the pandemic added a new dimension to this crisis, disrupting care pathways, delaying diagnoses, and exacerbating chronic conditions.2 The global focus on infection control often overshadowed these secondary effects.
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet
Public Health
|15th Jan, 2026
|The Lancet